PROCYSBI is a Oral Capsule, Delayed Release Pellets in the Human Prescription Drug category. It is labeled and distributed by Horizon Therapeutics Usa, Inc.. The primary component is Cysteamine Bitartrate.
Product ID | 75987-101_03837d9e-aee3-46e9-a893-b05a24397170 |
NDC | 75987-101 |
Product Type | Human Prescription Drug |
Proprietary Name | PROCYSBI |
Generic Name | Cysteamine Bitartrate |
Dosage Form | Capsule, Delayed Release Pellets |
Route of Administration | ORAL |
Marketing Start Date | 2013-04-30 |
Marketing Category | NDA / NDA |
Application Number | NDA203389 |
Labeler Name | Horizon Therapeutics USA, Inc. |
Substance Name | CYSTEAMINE BITARTRATE |
Active Ingredient Strength | 75 mg/1 |
Pharm Classes | Cystine Depleting Agent [EPC], Cystine Disulfide Reduction [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2013-04-30 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA203389 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2013-04-30 |
Ingredient | Strength |
---|---|
CYSTEAMINE BITARTRATE | 75 mg/1 |
SPL SET ID: | d3a3ec28-f746-463a-bb92-3bc8826db09e |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
75987-100 | PROCYSBI | Cysteamine bitartrate |
75987-101 | PROCYSBI | Cysteamine bitartrate |
75987-140 | PROCYSBI | Cysteamine bitartrate |
75987-145 | PROCYSBI | Cysteamine bitartrate |
0378-9040 | Cystagon | cysteamine bitartrate |
0378-9045 | Cystagon | cysteamine bitartrate |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
PROCYSBI 85550512 4407821 Live/Registered |
HORIZON ORPHAN LLC 2012-02-23 |